Specific inflammatory osteoclast precursors induced during chronic inflammation give rise to highly active osteoclasts associated with inflammatory bone loss

Abstract

Elevated osteoclast (OC) activity is a major contributor to inflammatory bone loss (IBL) during chronic inflammatory diseases. However, the specific OC precursors (OCPs) responding to inflammatory cues and the underlying mechanisms leading to IBL are poorly understood. We identified two distinct OCP subsets: Ly6ChiCD11bhi inflammatory OCPs (iOCPs) induced during chronic inflammation, and homeostatic Ly6ChiCD11blo OCPs (hOCPs) which remained unchanged. Functional and proteomic characterization revealed that while iOCPs were rare and displayed low osteoclastogenic potential under normal conditions, they expanded during chronic inflammation and generated OCs with enhanced activity. In contrast, hOCPs were abundant and manifested high osteoclastogenic potential under normal conditions but generated OCs with low activity and were unresponsive to the inflammatory environment. Osteoclasts derived from iOCPs expressed higher levels of resorptive and metabolic proteins than those generated from hOCPs, highlighting that different osteoclast populations are formed by distinct precursors. We further identified the TNF-α and S100A8/A9 proteins as key regulators that control the iOCP response during chronic inflammation. Furthermore, we demonstrated that the response of iOCPs but not that of hOCPs was abrogated in tnf-α−/− mice, in correlation with attenuated IBL. Our findings suggest a central role for iOCPs in IBL induction. iOCPs can serve as potential biomarkers for IBL detection and possibly as new therapeutic targets to combat IBL in a wide range of inflammatory conditions.

Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases

“… 57 Also, our TRAP staining verified that overactivated osteoclasts were blamed for inflammatory bone loss. 58 , 59 For treatment, intervening in the primary diseases and inhibiting inflammation are given priority. Thus, inhibiting immune cells, cytokine, osteoclastogenesis, and osteoclast activity is applicable.…”

Heat-Killed Staphylococcus aureus Induces Bone Mass Loss through Telomere Erosion

“…As a causative substance of Staphylococcus aureus , the most common pathogenic bacteria in clinical practice, HKSA is often used as an inflammatory inducer [ 16 , 17 , 18 , 19 ]. There is considerable evidence to show that chronic inflammation can lead to osteoporosis by inhibiting the osteogenic activity of osteogenic cells [ 22 , 23 , 24 ] or by promoting the bone resorptive activity of osteoclasts [ 23 , 24 , 25 ]. This study found that HKSA caused an increase in the number of OCN + cells, suggesting that HKSA may mainly lead to bone loss by inhibiting the osteogenic activity of osteogenic cells.…”

The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies

“…7 These proinflammatory factors have also been shown to expand a highly active osteoclast population derived from the Ly6C high /CD11b high cells. 138 Among these proinflammatory factors, IL-1 has been suggested to play a significant role in hematopoietic aging and myeloid malignancies.…”